APA-viite

Berglund, J., Vink, P., Tavares Da Silva, F., Lestrate, P., & Boutriau, D. (2014). Safety, Immunogenicity, and Antibody Persistence following an Investigational Streptococcus pneumoniae and Haemophilus influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults. American Society for Microbiology.

Chicago-tyylinen lähdeviittaus

Berglund, Johan, Peter Vink, Fernanda Tavares Da Silva, Pascal Lestrate, ja Dominique Boutriau. Safety, Immunogenicity, and Antibody Persistence Following an Investigational Streptococcus Pneumoniae and Haemophilus Influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults. American Society for Microbiology, 2014.

MLA-viite

Berglund, Johan, et al. Safety, Immunogenicity, and Antibody Persistence Following an Investigational Streptococcus Pneumoniae and Haemophilus Influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults. American Society for Microbiology, 2014.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.